Global Interactions with Healthcare Professionals


Working with Healthcare Professionals

The relationships between industry and healthcare professionals, or HCPs, and healthcare organizations, or HCOs, provide invaluable benefits to the advancement of modern medicine. As global healthcare has evolved, public interest in the nature of these relationships has grown along with public interest in understanding whether any potential conflicts of interest may arise as well. In response, a worldwide trend has been launched among various countries and industry groups to establish requirements for companies to disclose transfers of value made to HCPS and HCOs.

Bristol-Myers Squibb believes in fostering an open environment to help build a foundation of trust, credibility, and respect among our colleagues, healthcare providers, patients, stockholders, and the public. Bristol-Myers Squibb further believes that interactions with individuals and institutions in the healthcare delivery system should take place in an open, honest, and ethical manner. These interactions should be based on the pursuit of objective science and the communication of scientifically accurate information, and relate to matters that are important to healthcare providers and patients.

Our company is committed to supporting financial disclosure laws and codes as an extension of our own efforts to increase public awareness of the positive collaboration between industry and HCPs/HCOs.

Find out more about Interactions with HCPs and HCOs around the Globe. Select from the countries below for more information.